Health Experts: Say No to Randomized Trials Testing Ebola Drugs

By |2017-04-25T18:03:53+00:00November 24th, 2014|Pharma News|

Karla Burke Life Sciences Senior Marketing Specialist at Thomson ReutersTop Contributor Leading health experts said that having decided it is ethical to use non-approved products to help deal with the Ebola virus epidemic, it would be unethical if those drugs were administered in the context of randomized clinical trials. “No one insisted Western medical workers [...]

Read More
Comments Off on Health Experts: Say No to Randomized Trials Testing Ebola Drugs

Quorum Review’s New Offering for Phase I Ebola Studies

By |2014-11-21T15:17:38+00:00November 21st, 2014|Pharma News|

With the Ebola virus becoming a major global healthcare crisis, Quorum Review IRB recognizes the imperative nature for developing new vaccines and treatments quickly. To assist investigators, medical institutions, as well as pharmaceutical sponsors and CROs, we are offering initial board review for Phase I Ebola studies at NO CHARGE. http://us1.campaign-archive1.com/?u=75cdd3197c4f2f278789c2b54&id=fe3bcb24d8&e=728640ad3b

Read More
Comments Off on Quorum Review’s New Offering for Phase I Ebola Studies
Go to Top